loading
前日終値:
$7.73
開ける:
$7.72
24時間の取引高:
214.14K
Relative Volume:
1.30
時価総額:
$163.21M
収益:
$66.59M
当期純損益:
$-104.93M
株価収益率:
-1.5433
EPS:
-4.95
ネットキャッシュフロー:
$-96.48M
1週間 パフォーマンス:
+16.08%
1か月 パフォーマンス:
+6.55%
6か月 パフォーマンス:
+47.68%
1年 パフォーマンス:
-47.89%
1日の値動き範囲:
Value
$7.49
$7.89
1週間の範囲:
Value
$6.435
$8.11
52週間の値動き範囲:
Value
$4.09
$15.92

Enanta Pharmaceuticals Inc Stock (ENTA) Company Profile

Name
名前
Enanta Pharmaceuticals Inc
Name
セクター
Healthcare (1161)
Name
電話
617 607 0800
Name
住所
4 KINGSBURY AVENUE, WATERTOWN, MA
Name
職員
131
Name
Twitter
@EnantaPharma
Name
次回の収益日
2025-02-10
Name
最新のSEC提出書
Name
ENTA's Discussions on Twitter

ENTA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ENTA
Enanta Pharmaceuticals Inc
7.635 148.78M 66.59M -104.93M -96.48M -4.95
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
468.64 121.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
555.46 61.60B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.17 41.17B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
573.49 34.35B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.06 27.29B 3.81B -644.79M -669.77M -6.24

Enanta Pharmaceuticals Inc Stock (ENTA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2023-08-09 ダウングレード JP Morgan Neutral → Underweight
2023-08-08 ダウングレード Jefferies Buy → Hold
2022-12-09 開始されました H.C. Wainwright Buy
2022-07-06 アップグレード Evercore ISI In-line → Outperform
2022-06-01 アップグレード Evercore ISI Underperform → In-line
2021-10-07 開始されました Jefferies Buy
2021-09-09 開始されました SVB Leerink Mkt Perform
2021-01-29 アップグレード JP Morgan Underweight → Neutral
2020-11-24 開始されました Evercore ISI Underperform
2020-08-28 再開されました ROTH Capital Buy
2020-08-26 開始されました Piper Sandler Overweight
2020-07-27 アップグレード JMP Securities Mkt Perform → Mkt Outperform
2020-03-17 アップグレード Robert W. Baird Neutral → Outperform
2019-11-22 ダウングレード JMP Securities Mkt Outperform → Mkt Perform
2019-09-26 ダウングレード JP Morgan Neutral → Underweight
2019-05-24 開始されました Wolfe Research Outperform
2019-04-23 アップグレード Berenberg Hold → Buy
2018-12-13 開始されました Berenberg Hold
2018-06-06 開始されました ROTH Capital Buy
2018-02-08 ダウングレード JP Morgan Overweight → Neutral
2018-01-02 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2017-11-21 繰り返されました RBC Capital Mkts Outperform
2017-09-15 開始されました RBC Capital Mkts Outperform
2017-07-11 アップグレード JMP Securities Mkt Perform → Mkt Outperform
2016-04-28 ダウングレード JMP Securities Mkt Outperform → Mkt Perform
2016-02-09 繰り返されました Barclays Underweight
2015-10-23 ダウングレード Barclays Equal Weight → Underweight
2015-10-23 アップグレード JMP Securities Mkt Perform → Mkt Outperform
すべてを表示

Enanta Pharmaceuticals Inc (ENTA) 最新ニュース

pulisher
Jul 20, 2025

What analysts say about Enanta Pharmaceuticals Inc. stockStrong return on investment - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 20, 2025

What drives Enanta Pharmaceuticals Inc. stock priceFree Investment Case Studies - Autocar Professional

Jul 20, 2025
pulisher
Jul 19, 2025

Is Enanta Pharmaceuticals Inc. a good long term investmentSuperior profit margins - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

Enanta Pharmaceuticals Inc. Stock Analysis and ForecastDynamic profit opportunities - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

why enanta pharmaceuticals inc. stock attracts strong analyst attentionShort Term Risk Controlled Alerts - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Will Enanta Pharmaceuticals Inc. stock benefit from interest rate changesFast Growing Stocks - Newser

Jul 18, 2025
pulisher
Jul 16, 2025

Enanta Pharmaceuticals to Participate in Baird’s Biotech Discovery Series - BioSpace

Jul 16, 2025
pulisher
Jul 16, 2025

how enanta pharmaceuticals inc. stock performs during market volatilityFree Smart Investment Opportunities - Newser

Jul 16, 2025
pulisher
Jul 16, 2025

What makes Enanta Pharmaceuticals Inc. stock price move sharplyBreakout Momentum Stocks - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

How Enanta Pharmaceuticals Inc. stock performs during market volatilityFree Investment Community - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Enanta Pharmaceuticals Inc. stock attracts strong analyst attentionVolume Spike Monitors - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

(ENTA) On The My Stocks Page - news.stocktradersdaily.com

Jul 12, 2025
pulisher
Jul 10, 2025

Enanta Pharmaceuticals Insider Buyers Net US$65k Despite 11% Stock Decline - simplywall.st

Jul 10, 2025
pulisher
Jun 21, 2025

(ENTA) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Jun 21, 2025
pulisher
Jun 14, 2025

Enanta Pharmaceuticals’ SWOT analysis: stock shifts focus to immunology amid RSV progress - Investing.com Nigeria

Jun 14, 2025
pulisher
Jun 13, 2025

AbbVie Secures FDA Approval to Expand Mavyret’s Label - Yahoo Finance

Jun 13, 2025
pulisher
Jun 12, 2025

ENTA’s Market Quandary: Decoding the Ups and Downs of 2023 - investchronicle.com

Jun 12, 2025
pulisher
Jun 11, 2025

FDA Expands AbbVie's Mavyret Label To Include Acute Hepatitis C Treatment (CORRECTED) - Benzinga

Jun 11, 2025
pulisher
Jun 11, 2025

FDA Expands AbbVie's Mavyret Label To Include Acute Hepatitis C Treatment (CORRECTED) - Benzinga

Jun 11, 2025
pulisher
Jun 11, 2025

AbbVie wins FDA nod for Mavyret label expansion (ABBV:NYSE) - Seeking Alpha

Jun 11, 2025
pulisher
Jun 11, 2025

Enanta Pharmaceuticals' Partner AbbVie Receives U.S. FDA Approva - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Enanta Pharmaceuticals’ Partner AbbVie Receives U.S. FDA Approval of an Expanded Indication for MAVYRET® (glecaprevir/pibrentasvir) as the First and Only Treatment for People with Acute Hepatitis C Virus - Yahoo Finance

Jun 11, 2025
pulisher
Jun 10, 2025

(ENTA) Proactive Strategies - news.stocktradersdaily.com

Jun 10, 2025
pulisher
Jun 04, 2025

Enanta Pharmaceuticals (NASDAQ:ENTA) Given New $24.00 Price Target at JMP Securities - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Enanta Pharma (ENTA) Receives Target Price Boost from JMP Securi - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Enanta (ENTA) Price Target Raised as Key Clinical Results Antici - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Enanta (ENTA) Price Target Raised as Key Clinical Results Anticipated | ENTA Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Citizens JMP raises Enanta Pharmaceuticals stock price target to $24 By Investing.com - Investing.com UK

Jun 03, 2025
pulisher
May 27, 2025

Enanta Pharmaceuticals to Present at the Jefferies Global Healthcare Conference - BioSpace

May 27, 2025
pulisher
May 27, 2025

Enanta Pharmaceuticals to Present at the Jefferies Global Health - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Enanta Pharmaceuticals to Present at the Jefferies Global Healthcare Conference | ENTA Stock News - GuruFocus

May 27, 2025

Enanta Pharmaceuticals Inc (ENTA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$21.80
price up icon 0.55%
$35.81
price up icon 0.50%
$103.45
price up icon 0.67%
$26.32
price up icon 0.15%
$109.96
price up icon 0.27%
biotechnology ONC
$294.68
price up icon 0.93%
大文字化:     |  ボリューム (24 時間):